Kopran Ltd. logo

Kopran Ltd. (KOPRAN)

Market Open
10 Aug, 10:00
XNSE XNSE
177. 71
-3.51
-1.9369%
14.93B Market Cap
- P/E Ratio
12% Div Yield
172,943 Volume
- Eps
181.22
Previous Close
Add Transaction
Day Range
175 181.22
Year Range
107 219
Want to track KOPRAN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

KOPRAN trading today lower at ₹177.71, a decrease of -1.9369% from yesterday's close, completing a monthly decrease of -6.4684% or -₹12.29. Over the past 12 months, KOPRAN stock gained 17.3778%.
KOPRAN pays dividends to its shareholders, with the most recent payment made on Oct 11, 2025. The next announced payment will be in In 1 month on Sep 17, 2026 for a total of ₹3.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Kopran Ltd. has completed 1 stock splits, with the recent split occurring on Apr 08, 1994.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

KOPRAN Chart

People also search for

Syngene International Ltd.
405.4
+0.2721%
Doms Industries Ltd.
2,248.4
-0.0756%
Rainbow Children's Medicare Pvt. Ltd.
1,533.3
-0.3445%
Medplus Health Services Ltd.
680.85
-0.7941%
Marksans Pharma Ltd.
275.5
+1.492%

Kopran Ltd. (KOPRAN) FAQ

What is the stock price today?

The current price is ₹177.71.

On which exchange is it traded?

Kopran Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is KOPRAN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 12%.

What is its market cap?

As of today, the market cap is 14.93B.

Has Kopran Ltd. ever had a stock split?

Kopran Ltd. had 1 splits and the recent split was on Apr 08, 1994.

Kopran Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
XNSE Exchange
Y4821P114 CUSIP
India Country
842 Employees
11 Aug 2026 Last Dividend
8 Apr 1994 Last Split
- IPO Date

Overview

Kopran Limited is an integrated pharmaceutical company with a broad global reach, known for its production and distribution of active pharmaceutical ingredients and finished dosage formulations. Established in 1958 and headquartered in Mumbai, India, Kopran has carved a niche for itself in the pharmaceutical industry both domestically and internationally. The company stands out for its comprehensive range of products delivered in various dosage forms, catering to a wide spectrum of therapeutic categories. With a strong emphasis on quality and innovation, Kopran Limited continues to expand its presence, providing essential drugs to meet the diverse needs of patients worldwide.

Products and Services

Kopran Limited's product portfolio is extensive, covering multiple therapeutic areas and dosage forms. Below is an overview of their main products and services:

  • Tablets, Capsules, Syrups, Dry Powder, Suspension, and Injectables: Kopran manufactures a wide array of pharmaceutical products in these conventional dosage forms to cater to different patient needs and preferences, ensuring efficiency and convenience in drug delivery.
  • Branded and Generic Formulations: The company offers both proprietary branded medications and generic drugs, providing affordable treatment options without compromising on quality.
  • Therapeutic Categories:
    • Macrolide & Antibacterial: Offering solutions for bacterial infections, Kopran's range includes both broad-spectrum and targeted antibiotics.
    • Anticonvulsant: Medications designed to prevent or reduce the severity of epileptic seizures and other seizure disorders.
    • Anti-hypertensive: Drugs used in managing hypertension, helping reduce the risks associated with high blood pressure.
    • Anti-helmentics & Anti-acne: Treatments for parasitic worm infestations and acne-related skincare solutions.
    • Anti-infective & Anti-thrombotic: Medications aimed at preventing and treating infections and those that prevent blood clot formation respectively.
    • Antidiabetic: Drugs for the control and management of diabetes by regulating blood glucose levels.
    • Pain Management: A range of analgesics for managing acute and chronic pain.
    • Neuromodular, Gastroenterology, and Cardiovascular: Medications addressing disorders of the nervous system, digestive tract, and cardiovascular system.
    • Erectile Dysfunction, Antiallergics, Respiratory: Treatments for sexual dysfunction, allergic reactions, and respiratory conditions.
    • Oncology & Central Nervous System (CNS): Drugs for cancer treatment and managing disorders of the CNS.
    • Antiprotozoal, Anthelmintics, Antipeptic Ulcer & Gut: Treatments for infections caused by protozoa, worms, and gastrointestinal ulcers.

Contact Information

Address: Parijat House
Phone: 91 22 4366 1111